Blog
RSS FeedPosted by Michael Wonder on 08 Oct 2024
Updated information about PHARMAC's priority lists
8 October 2024 - PHARMAC’s quarterly Pūahoaho Report provides the latest information about applications for medicines, vaccines, and related products that ...
Posted by Michael Wonder on 01 Oct 2024
Rollout of new medicines across New Zealand begins
1 October 2024 - Today marks the first day a range of new medicines, including cancer medicines, will start to ...
Posted by Michael Wonder on 01 Oct 2024
New Zealand Pharmaceutical Schedule - 1 October 2024
1 October 2024 - The October 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Sep 2024
Thousands benefit from PHARMAC decision to fund oestradiol gel
26 September 2024 - PHARMAC has decided to fund oestradiol gel, a type of hormone treatment, it estimates 18,000 people will ...
Posted by Michael Wonder on 24 Sep 2024
Improved access to medicines for urinary tract infections and Parkinson's disease
24 September 2024 - PHARMAC is widening access to a medicine to treat urinary tract infections and funding a combination ...
Posted by Michael Wonder on 18 Sep 2024
Making more new cancer treatments available for New Zealanders
18 September 2024 - PHARMAC is consulting on a proposal to fund the medicine lenvatinib mesylate for three types of cancer ...
Posted by Michael Wonder on 17 Sep 2024
5,700 people to benefit from widened access to funded medicines
17 September 2024 - PHARMAC is widening access to seven medicines, benefitting an estimated 5,700 people within the first year ...
Posted by Michael Wonder on 13 Sep 2024
Proposal to fund medicines for lung cancer, breast cancer, and respiratory conditions
13 September 2024 - PHARMAC is seeking feedback on a proposal to fund four new medicines for cancer and respiratory ...
Posted by Michael Wonder on 11 Sep 2024
New medicine and an easier renewal process proposed for people with ADHD
12 September 2024 - PHARMAC is asking for feedback on two changes for people with attention deficit hyperactivity disorder - ...
Posted by Michael Wonder on 09 Sep 2024
First cancer medicine decision following PHARMAC funding boost
9 September 2024 - PHARMAC has decided to widen access to two medicines for several types of cancer. ...
Posted by Michael Wonder on 31 Aug 2024
New Zealand Pharmaceutical Schedule - 1 September 2024
1 September 2024 - The September 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 21 Aug 2024
PHARMAC proposes to widen access to medicine used in the treatment of heart failure
20 August 2024 - PHARMAC is consulting on plans to widen access to empagliflozin, a medicine used in the treatment ...
Posted by Michael Wonder on 09 Aug 2024
PHARMAC indicates interest in funding cancer treatment bevacizumab
9 August 2024 - PHARMAC is seeking commercial bids from suppliers for the supply of bevacizumab for a range of ...
Posted by Michael Wonder on 05 Aug 2024
Significant step forward proposed for bowel cancer
5 August 2024 - PHARMAC is looking to fund a medicine for bowel cancer that would help people live longer. ...
Posted by Michael Wonder on 01 Aug 2024
PHARMAC closes inactive medicine applications for greater clarity
1 August 2024 - PHARMAC has removed over 500 inactive medicine applications from its lists in the past five years ...